{"disease":{"id":"moderate-covid-19-infection","name":"moderate covid 19 infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04762186","title":"Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Universitätsklinikum Köln","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}